Resources from the same session
5308 - Chemotherapy plus local-regional radiotherapy versus chemotherapy alone in primary metastatic nasopharyngeal carcinoma: a randomized, open-label, phase 3 trial
Presenter: Mingyuan Chen
Session: Proffered Paper – Head and neck cancer
Resources:
Abstract
3257 - A phase II study of Monalizumab in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN): results of the I1 cohort of the EORTC-HNCG-1559 trial (UPSTREAM).
Presenter: Rachel Galot
Session: Proffered Paper – Head and neck cancer
Resources:
Abstract
Slides
Webcast
3250 - Personalized treatment according to geriatric assessment in 1st line recurrent and/or metastatic (R/M) Head and Neck Squamous Cell Cancer (HNSCC) patients aged 70 or over. ELAN (ELderly heAd and Neck cancer) FIT and UNFIT trials
Presenter: Joel Guigay
Session: Proffered Paper – Head and neck cancer
Resources:
Abstract
Slides
Webcast
2064 - Cisplatin reduces costs and provides more quality adjusted life years (QALYs) than cetuximab in chemoradiotherapy for patients with HPV-Positive Oropharyngeal Cancer (HPV+OPC)
Presenter: David Jones
Session: Proffered Paper – Head and neck cancer
Resources:
Abstract
Slides
Webcast
1432 - Double-blind Randomized Phase 2 Results Comparing Concurrent High-dose Cisplatin Chemorradiation (CRT) plus Debio 1143 or Placebo In High-risk Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN): A GORTEC Study
Presenter: Jean Bourhis
Session: Proffered Paper – Head and neck cancer
Resources:
Abstract
Slides
Webcast
Proffered Paper – Head and neck cancer - Invited Discussant LBA65, 1108O and 1109O
Presenter: Marco Merlano
Session: Proffered Paper – Head and neck cancer
Resources:
Slides
Webcast